Digestive Health OTC
•10 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (10)
%
| Company | Market Cap | Price |
|---|---|---|
|
OTC digestive health products are sold through CVS retail channels.
|
$98.55B |
$77.90
-0.33%
|
|
Provides OTC digestive health products (ENO) directly to consumers.
|
$41.10B |
$9.00
-0.22%
|
|
Digestive health OTC products are part of the consumer health/OTC portfolio.
|
$11.96B |
$14.34
+1.63%
|
|
Walgreens markets digestive health OTC products (antacids, etc.) sold directly to consumers.
|
$10.36B |
$11.98
|
|
Digestive health OTC products are a product category Albertsons offers in-store.
|
$9.86B |
$17.12
-1.10%
|
|
PBH's Dramamine and Fleet brands position it in the Digestive Health OTC segment.
|
$3.01B |
$61.00
-2.80%
|
|
Gastrointestinal health products are a recognized OTC category in Perrigo's portfolio.
|
$2.92B |
$21.25
-1.67%
|
|
The company discusses a potential OTC switch for VOQUEZNA, aligning with Digestive Health OTC products.
|
$825.20M |
$11.82
+0.17%
|
|
Digestive Health OTC private-label products.
|
$37.68M |
$4.38
-8.68%
|
|
Gelteq's non-prescription digestive health products align with the Digestive Health OTC category.
|
$10.55M |
$1.30
-2.99%
|
Loading industry metrics...
Loading comparison data...
